INSP
Back in the black
Inspire Medical Systems just pulled off the classic investor plot twist: after a rough stretch, the company reported a return to profitability in Q2. That’s the kind of headline that can make a stock do a double take.
Why you should care
Profitability matters, obviously, but so does the part hiding behind the curtain: Inspire also raised its FY26 outlook. Translation: management is sounding a little more confident about the rest of the year, and that usually gets the market leaning in.
The nerdy but important part
If you own the stock, you’re probably asking two things:
- Was this profit comeback driven by better core demand, tighter costs, or just a one-off boost?
- Does the improved FY26 outlook mean the business is finally finding its footing?
Investors tend to reward a company when the story shifts from “can they stabilize?” to “can they scale?” Inspire’s update nudges that conversation in the right direction.
Big picture
A single profitable quarter doesn’t make a comeback story, but it can absolutely change the vibe. If Inspire can stack a few more of these together, today’s headline starts looking less like a blip and more like a trend.